Phibro Animal Health
PAHC
Phibro Animal Health (PAHC) earnings history
Most recent quarter
- Fiscal period
- Q4 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.85
- EPS estimate
- $0.71
- EPS surprise
- +19.25%
- Revenue surprise
- +4.07%
- Revenue
- $396.7M
- Revenue estimate
- $381.2M
- Reported
- Aug 26, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2026 | Aug 26, 2026 | $0.71 | $0.85 | +19.25% | $396.7M | SEC |
| Q3 2026 | May 6, 2026 | $0.71 | $0.76 | +6.59% | $383.5M | SEC |
| Q2 2026 | Feb 4, 2026 | $0.67 | $0.87 | +29.85% | $373.9M | SEC |
| Q1 2026 | Nov 5, 2025 | $0.62 | $0.73 | +17.27% | $363.9M | SEC |
| Q4 2025 | Aug 27, 2025 | $0.52 | $0.57 | +9.34% | $378.7M | SEC |
| Q3 2025 | May 7, 2025 | $0.52 | $0.63 | +21.04% | $347.8M | SEC |
| Q2 2025 | Feb 5, 2025 | $0.43 | $0.54 | +27.06% | $309.3M | SEC |
| Q1 2025 | Nov 6, 2024 | $0.25 | $0.35 | +41.13% | $260.4M | SEC |
| Q4 2024 | Aug 28, 2024 | $0.33 | $0.41 | +23.01% | $273.2M | SEC |
| Q3 2024 | May 8, 2024 | $0.29 | $0.31 | +6.90% | $263.2M | SEC |
| Q2 2024 | Feb 7, 2024 | $0.28 | $0.33 | +17.86% | $249.9M | SEC |
| Q1 2024 | Nov 8, 2023 | $0.23 | $0.14 | −39.13% | $231.3M | SEC |
| Q4 2023 | Aug 30, 2023 | $0.37 | $0.38 | +2.01% | $255.0M | SEC |
| Q3 2023 | May 3, 2023 | $0.34 | $0.29 | −13.43% | $245.7M | SEC |
| Q2 2023 | Feb 8, 2023 | $0.30 | $0.34 | +12.40% | $244.6M | SEC |
| Q1 2023 | Nov 9, 2022 | $0.26 | $0.21 | −20.24% | $232.5M | SEC |
| Q4 2022 | Aug 24, 2022 | $0.38 | $0.36 | −4.43% | $255.3M | SEC |
| Q3 2022 | May 4, 2022 | $0.35 | $0.33 | −6.59% | $239.6M | — |
| Q2 2022 | Feb 9, 2022 | $0.33 | $0.37 | +12.91% | $232.7M | — |
| Q1 2022 | Nov 2, 2021 | $0.29 | $0.25 | −14.76% | $214.7M | — |
Quarterly revenue
Frequently asked questions
When did Phibro Animal Health (PAHC) last report earnings?
Phibro Animal Health last reported on Aug 26, 2026, covering fiscal Q4 2026.
Did PAHC beat earnings estimates?
Yes. Phibro Animal Health reported EPS of $0.85 for Q4 2026 against a $0.71 estimate — a 19.25% beat.
How much revenue did PAHC report last quarter?
Phibro Animal Health reported $396.7M in revenue for Q4 2026, against a consensus estimate of $381.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.